John D Fraser bought $7,375 of AWHL
director at Aspira Women's Health Inc.. 16,389 shares at an average of $0.45, traded Sep 17, 2025, filed Sep 19, 2025.
Score components
- +15RoleDirector
- 0Trade size$7k at market
- 0Relative to holdingsHoldings up 3.0%
- 0Price contextNo price history yet
- +15Cluster3 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001493152-25-014233, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 17, 2025 | POpen-market purchase Common Stock | +16,389 | $0.45 | $7,375 | 566,393 | Sep 19, 2025 |
| Sep 17, 2025 | POpen-market purchase Warrant (Right to Buy)derivative | +12,292 | $0.00 | $0 | 981,549 | Sep 19, 2025 |
Related signals
Other insiders at Aspira Women's Health Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 28Weak | AWHLbuy Aspira Women's Health Inc. | Jack W Schuler owner | $100k 222,222 shares | +6% | |
| 38Weak | Aspira Women's Health Inc. | Jeffrey k cohen director | $25k 55,556 shares | +17% | |
| 46Moderate | Aspira Women's Health Inc. | Jack W Schuler owner | $500k 1,111,111 shares | +41% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.